PNC Financial Services Group’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.7K Buy
987
+206
+26% +$4.87K ﹤0.01% 3595
2025
Q4
$20.6K Buy
781
+468
+150% +$10.2K ﹤0.01% 3642
2025
Q3
$5.35K Sell
313
-25
-7% -$358 ﹤0.01% 4177
2025
Q2
$4.24K Buy
338
+108
+47% +$1.29K ﹤0.01% 4200
2025
Q1
$2.74K Sell
230
-54
-19% -$736 ﹤0.01% 4258
2024
Q4
$4.16K Buy
284
+280
+7,000% +$3.92K ﹤0.01% 4093
2024
Q3
$50 Buy
+4
New +$44 ﹤0.01% 4745
2024
Q2
Sell
-14
Closed -$147 4931
2024
Q1
$147 Buy
14
+5
+56% +$56 ﹤0.01% 4627
2023
Q4
$94 Buy
+9
New +$72 ﹤0.01% 4521
2022
Q4
Sell
-178
Closed -$1K 4863
2022
Q3
$1K Buy
+178
New +$1.07K ﹤0.01% 4363

Other funds holding ZYME

PNC Financial Services Group's ZYME Position: Q1 2026 in Review

PNC Financial Services Group increased its Zymeworks (ZYME) stake by 26% in Q1 2026, buying an estimated $4.87K and bringing the position to 987 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3595.

PNC Financial Services Group first reported a position in ZYME in Q3 2022 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • PNC Financial Services Group held 987 shares of Zymeworks worth $24.7K as of Q1 2026.
  • PNC Financial Services Group bought 206 Zymeworks shares in Q1 2026, an estimated $4.87K.
  • Zymeworks made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3595 holding.
  • PNC Financial Services Group first reported a position in Zymeworks in Q3 2022 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.